FDC Wins Approval for Ciprofloxacin Ophthalmic Solution
Posted on: Thursday, 3 July 2008, 09:01 CDT
FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution.
FDC's Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections.
The company has recently received approval for Timolol maleate ophthalmic solution. Another abbreviated new drug application Ofloxacin ophthalmic solution is in the final stages of approval.
Source: Datamonitor
Related Articles
- Hi-Tech Pharmacal Receives Final Approval for Dorzolamide Ophthalmic Solution
- FDA Approves Akorn's Ofloxacin Ophthalmic Solution
- FDA Grants Tentative Approval for Hi-Tech's Generic Ophthalmic Solution
- Hi-Tech Pharmacal Receives Tentative Approval for Dorzolamide Hydrochloride With Timolol Maleate Ophthalmic Solution
- Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution) 0.2%/0.5%
- Alcon's Treatment of Glaucoma and Ocular Hypertension, TRAVATANZ(TM) Solution, Approved in Japan
- Alcon's Eye Allergy Drug, PATANOL(R) Ophthalmic Solution, Approved in Japan
- Mast Cell Stabilization and Anti-Histamine Effects of Olopatadine Ophthalmic Solution: a Review of Pre-Clinical and Clinical Research
- Comparative Efficacy of Olopatadine 0.1% Ophthalmic Solution Versus Levocabastine 0.05% Ophthalmic Suspension Using the Conjunctival Allergen Challenge Model
Rating: 3.2 / 5 (9 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds